FDA Grants De Novo Marketing Authorization for
Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the Leading Cause of...
Source: globenewswire.com
Prognostic Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prognostic Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prognostic Test Today - Breaking & Trending Today
Renalytix test gets US FDA marketing authorisation
Renalytix announced on Friday that the US Food and Drug Administration (FDA) had granted De Novo marketing authorisation for its ‘KidneyIntelX.dkd’ prognostic test.
Source: sharecast.com